The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 105: Early Phase 1 Clinical Trials" during the SITC 2018 Annual Meeting on November 9, 2018. Available here are the presentation slides and video from the session.33rd Annual Meeting Organizers
Meeting: SITC 33 Annual Meeting: Concurrent Session 105: Early Phase 1 Clinical Trials; Presenter: Aung Naing, MD, FACP – University of Texas MD Anderson Cancer Center; Date: November 9, 201800:10:01
Meeting: SITC 33 Annual Meeting: Concurrent Session 105: Early Phase 1 Clinical Trials; Presenter: Talia Golan – Sheba Medical Center; Date: November 9, 201800:13:07
Meeting: SITC 33 Annual Meeting: Concurrent Session 105: Early Phase 1 Clinical Trials; Presenter: Nehal Lakhani, MD, PhD – START-Midwest; Date: November 9, 201800:16:35
Meeting: SITC 33 Annual Meeting: Concurrent Session 105: Early Phase 1 Clinical Trials; Presenter: Adnam Khattak, MD – Perth University; Date: November 9, 201800:10:51
Meeting: SITC 33 Annual Meeting: Concurrent Session 105: Early Phase 1 Clinical Trials; Presenter: Diwakar Davar, MD – University of Pittsburgh Department of Medicine; Date: November 9, 201800:15:44
Meeting: SITC 33 Annual Meeting: Concurrent Session 105: Early Phase 1 Clinical Trials; Presenter: Timothy Yap, MD – University of Texas MD Anderson Cancer Center; Date: November 9, 201800:13:59
Meeting: SITC 33 Annual Meeting: Concurrent Session 105: Early Phase 1 Clinical Trials; Presenter: Dmitriy Zamarin, MD, PhD – Memorial Sloan Kettering Cancer Center; Date: November 9, 201800:12:05
Meeting: SITC 33 Annual Meeting; Concurrent Session 105: Early Phase 1 Clinical Trials; Presentation: Session Introduction; Presenter: David S. Hong, MD – University of Texas MD Anderson Cancer Center; Date: November 9, 201800:01:28
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us